Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD8630 in uncontrolled asthma (LEVANTE)
NCT06529419Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Aug 2024
- Primary completion
- Feb 2026
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 23
01
Overview
A Phase 2 trial of azd8630 in asthma, sponsored by AstraZeneca. Started Aug 2024; status: completed.
02
Drugs
azd8630
03
Conditions
asthma
Beyond the preview
Go deeper on NCT06529419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06529419.